Insulin, pacemakers, artificial corneas ― Ontario has a proud history of groundbreaking medical firsts. But with groundbreaking advances in cancer treatments, ultrasounds, vision assistance, medical AI and regenerative medicine (to name just a few), Ontario has proven that innovation isn’t just in our past, it’s our future. That’s why we are proud to be bringing 16 innovative companies to this year’s RESI Conference. From cancer treatments to X-rays, the companies that make up Ontario’s delegation this year run the full gamut of life sciences technologies. The lineup isn’t yet final but will be featured on our events hub at SourceFromOntario.com once it is. About RESI RESI is a landmark conference in the life sciences investment space. Like many events, this year’s conference is taking a new format as it moves to an all-digital event, but its goal remains the same: to pair emerging life sciences, medtech, and pharmaceutical companies with innovation-minded investors. This year’s conference is estimating attendance to be 1,000 entrepreneurs and investors, aiming for a 1:1 balance between the two. With thousands of meetings, dozens of pitch sessions, and over 96 hours of uninterrupted networking, RESI is a must-attend for anyone in the life sciences sector that is seeking funding or opportunities. About Ontario With a storied past and a bright future, Ontario is a place where both multi-national and home-grown organizations succeed. Find out why on our Life Sciences, Medtech, and Pharmaceuticals sector pages.
spotlightsOntario Investment RoundupIn 2022, we saw billions in investments in the automotive, advanced manufacturing and life sciences industries. In 2023, we’re showing no signs of slowing down.... Op EdUnleashing Innovation and Collaboration: Ontario, Canada’s Life Sciences Sector Leads the WaySenior Economic Officers Aaron Pinto and Chelsea Peet discuss Ontario’s key life sciences value propositions and what makes the province a leader in the sector.... success storiesOntario has the secret recipe for a thriving clinical trials environmentOntario has long been an attractive jurisdiction for high-quality clinical trials, but within the last decade, its activity outranks other global jurisdictions. ... success storiesOntario congratulates AstraZeneca on investment in Ontario to advance the fight against cancer and rare diseasesDiscover Ontario’s growing life sciences sector with AstraZeneca’s announcement of investment in clinical trials bringing 500 new jobs in Peel and the surrounding region.... spotlightsOntario, Canada ranks top 5 for FDI into North AmericaIn a world in economic flux, fDi Intelligence’s 2022 Global Greenfield Investment Trends reveals the province’s FDI investments show no sign of slowing down.... success storiesOntario biotech startup receives Gates Foundation grant to make contraceptives more accessibleOntario-based Cyclica’s new-age AI is generating more non-hormonal contraceptive choices for women in developing countries.... Press ReleaseOntario attracts economic opportunities with Trade Mission to IndiaThe Ontario government has concluded a successful trade mission to India to strengthen relationships with economic partners and attract new investments in key sectors.... spotlights14 AI companies to watch in 2022-23AI companies in Ontario are innovating at an astonishing pace across all industries. Their success represents an attractive investment proposition for companies...